Patents by Inventor Elena Paskaleva

Elena Paskaleva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOSYNTHETIC HEPARIN
    Publication number: 20230151400
    Abstract: The present disclosure relates to synthesis of heparin, which may be bioequivalent to porcine USP Heparin Sodium. The synthesis may involve three intermediates starting from heparosan.
    Type: Application
    Filed: January 20, 2023
    Publication date: May 18, 2023
    Applicant: Rensselaer Polytechnic Institute
    Inventors: Marc DOUAISI, Navdeep GROVER, Payel DATTA, Elena PASKALEVA, Lei LIN, Paul BRODFUEHRER, Trevor J. SIMMONS, Akihiro ONISHI, Makoto HIRAKANE, Li FU, Kevin LI, Robert J. LINHARDT, Jonathan DORDICK, Daisuke MORI
  • Biosynthetic heparin
    Patent number: 11591628
    Abstract: The present disclosure relates to synthesis of heparin, which may be bioequivalent to porcine USP Heparin Sodium. The synthesis may involve three intermediates starting from heparosan.
    Type: Grant
    Filed: September 7, 2017
    Date of Patent: February 28, 2023
    Assignee: Rensselaer Polytechnic Institute
    Inventors: Marc Douaisi, Navdeep Grover, Payel Datta, Elena Paskaleva, Lei Lin, Paul Brodfuehrer, Trevor J. Simmons, Akihiro Onishi, Makoto Hirakane, Li Fu, Kevin Li, Robert J. Linhardt, Jonathan Dordick, Daisuke Mori